(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CAROL FARMACIA RX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

CAROL FARMACIA RX

ST13

US500000090805882

Class

35, 44

Filing

90805882

Registration

7069350

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

33

Latest update

05/30/2023

Trademark type

Combined

Nice classes

35, 44

Filing date

07/01/2021

Registration date

05/30/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/30/2023

Last transaction

05/30/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

03/15/1987

First use in commerce

10/05/2005

Drawing code

3

Owner type

16

Owner location

Santo Domingo, D.N., DO

Examiner

STANWOOD, STEPHEN D

Law office

M60

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the name "CAROL" (stylized as "CaRol") with the letters "C", "A", "O", and "L" in green color and the letter "R" in red color. The letter "X" in red color is connected with the "R" to form the prescription symbol. Below is the word "FARMACIA" in upper-case and black color.

Holders and representatives

Holders

GRUPO CAROL, S.A.S.

Representatives

Alexis Jesús Colón COLÓN & PARTNERS

Technical classification

Nice Classes

Class 35Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

(Based on Use in Commerce) Retail pharmacy services

Class 44

(Based on 44(e)) Medical services

Publications

History of USPTO decisions and trademark events.

33 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/30/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

05/30/2023

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

04/26/2023

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

04/25/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/25/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/25/2023

ALIE

ASSIGNED TO LIE

04/25/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/17/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/03/2023

GNRT

NON-FINAL ACTION E-MAILED

04/03/2023

CNRT

SU - NON-FINAL ACTION - WRITTEN

04/03/2023

SUPC

STATEMENT OF USE PROCESSING COMPLETE

03/24/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

03/24/2023

IUAF

USE AMENDMENT FILED

03/09/2023

EISU

TEAS STATEMENT OF USE RECEIVED

03/09/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

12/27/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/01/2022

PUBO

PUBLISHED FOR OPPOSITION

11/01/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/12/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/23/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/20/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/19/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/19/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/23/2022

GNRT

NON-FINAL ACTION E-MAILED

03/23/2022

CNRT

NON-FINAL ACTION WRITTEN

03/23/2022

DOCK

ASSIGNED TO EXAMINER

03/23/2022

AMPX

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

11/09/2021

ALIE

ASSIGNED TO LIE

11/08/2021

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

11/03/2021

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

09/14/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/13/2021

NWAP

NEW APPLICATION ENTERED

07/05/2021

Continuous trademark protection

Get notified about every new filing that threatens CAROL FARMACIA RX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.